# Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer

> **NCT01880658** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT01880658
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2016-05
- **Final completion:** 2019-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01880658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01880658, "Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01880658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*